ARCHIVES

PCORI Approves $54.8 Million For Clinical Effectiveness Research

This article is from The Cancer Letter archive.

Vol. 40 No. 31 | August 1, 2014

Download PDF Visit The Full Archive

Related Articles

Review Of NCI Intramural Program Offers Over 60 Recommendations For Change

July 7, 1995

Iniparib Plus Chemo Shows Benefit In Phase II Study

January 28, 2011

FDA Describes Meeting With NCI In “Limited” Memo

May 7, 1976

Eight States Get Cervical Cancer Screening Planning Contracts

June 21, 1974

5-Day Strut-based Brachytherapy Produced Low Recurrence Rates

May 25, 2012

NCI Formaldehyde Finding Criticized

March 7, 1986